comparemela.com
Home
Live Updates
Should You Pick Boston Scientific Stock After A Solid Q4 And 13% Uptick This Year? : comparemela.com
Should You Pick Boston Scientific Stock After A Solid Q4 And 13% Uptick This Year?
The company reported revenue of $3.7 billion and adjusted earnings of $0.55 per share, compared to the consensus estimates of $3.6 billion and $0.51, respectively.
Related Keywords
China ,
Boston ,
Massachusetts ,
United States ,
Relievant Medsystems ,
Apollo Endosurgery ,
Health Care ,
Boston Scientific ,
Trefis High Quality Portfolio ,
Bsx ,
S Ampp 500 ,
S Amp P ,
Bsx Stock ,
Bsx Revenue ,
comparemela.com © 2020. All Rights Reserved.